ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease

ClinicalTrials.gov ID: NCT05766813

Public ClinicalTrials.gov record NCT05766813. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 20, 2026, 7:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease

Study identification

NCT ID
NCT05766813
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Intra-Cellular Therapies, Inc.
Industry
Enrollment
132 participants

Conditions and interventions

Interventions

  • Lenrispodun Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 12, 2023
Primary completion
Aug 31, 2025
Completion
Sep 30, 2025
Last update posted
Oct 22, 2024

2023 – 2025

United States locations

U.S. sites
31
U.S. states
14
U.S. cities
30
Facility City State ZIP Site status
Clinical Site Phoenix Arizona 85013 Recruiting
Clinical Site Scottsdale Arizona 85251 Recruiting
Clinical Site Irvine California 92697 Recruiting
Clinical Site Loma Linda California 92354 Recruiting
Clinical Site Altamonte Springs Florida 32714 Recruiting
Clinical Site Boca Raton Florida 33486 Recruiting
Clinical Site Coral Springs Florida 33067 Recruiting
Clinical Site Hallandale Florida 33009 Recruiting
Clinical Site Maitland Florida 32751 Not yet recruiting
Clinical Site Miami Florida 33136 Recruiting
Clinical Site Ocala Florida 34470 Recruiting
Clinical Site Orlando Florida 32804 Recruiting
Clinical Site Orlando Florida 32825 Recruiting
Clinical Site Port Orange Florida 32127 Recruiting
Clinical Site Tampa Florida 33612 Recruiting
Clinical Site Augusta Georgia 30912 Recruiting
Clinical Site Decatur Georgia 30030 Recruiting
Clinical Site Kansas City Kansas 66160 Recruiting
Clinical Site Farmington Hills Michigan 48334 Recruiting
Clinical Site Golden Valley Minnesota 55427 Recruiting
Clinical Site Albany New York 12208 Not yet recruiting
Clinical Site Rock Hill South Carolina 29732 Recruiting
Clinical Site Memphis Tennessee 38157 Recruiting
Clinical Site Austin Texas 78746 Recruiting
Clinical Site Dallas Texas 75243 Recruiting
Clinical Site Georgetown Texas 78628 Recruiting
Clinical Site Falls Church Virginia 22042 Recruiting
Clinical Site Henrico Virginia 23233 Recruiting
Clinical Site Kirkland Washington 98034 Recruiting
Clinical Site Spokane Washington 99202 Recruiting
Clinical Site Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05766813, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 22, 2024 · Synced Apr 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05766813 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →